Supplementary protection
LT - Amidu pakeistieji heterocikliniai junginiai, naudotini kaip IL-12, IL-23 ir (arba) IFN-alfa moduliatoriai
EN - AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN-ALPHA
SPC
| (11) |
Number of the document |
C 2922846 |
| (68) |
Number of the document |
2922846
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2023 523 |
| (22) |
Date of filing the application |
2023-08-23 |
| (41) |
Date of publication of the application |
2023-09-11 |
|
Date of publication of SPC |
2024-10-25 |
| (24) |
Date of coming into effect of SPC |
2033-11-08 |
Applicant
| (71) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
Grantee
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/23/1718, 2023-03-24
|
Calculated date of expiry of the SPC
| (94) |
2038-03-27 |
Name of the product protected by the basic patent
| (95) |
Deukravacitinibas arba farmaciniu požiūriu priimtina jo druska |
